These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16546843)

  • 1. Effect of doxazosin on oxidative stress related proteins in essential hypertensive patients.
    Calò LA; Bertipaglia L; Pagnin E; Davis PA; Sartori M; Semplicini A; Pessina AC
    Clin Exp Hypertens; 2006 Feb; 28(2):181-8. PubMed ID: 16546843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of doxazosin on oxidative stress-related proteins in benign prostatic hyperplasia.
    Calò LA; Pagnin E; Davis PA; Lodde M; Mian C; Semplicini A; Pycha A
    Urol Int; 2006; 76(1):36-41. PubMed ID: 16401919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
    Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J
    Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of olmesartan on oxidative stress in hypertensive patients: mechanistic support to clinical trials derived evidence.
    Cal LA; Maso LD; Caielli P; Pagnin E; Fusaro M; Davis PA; Pessina AC
    Blood Press; 2011 Dec; 20(6):376-82. PubMed ID: 21504378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of NAD(P)H oxidase p22 phox gene polymorphism on vascular aging in Korean centenarian and nonagenarian.
    Kim KI; Na JE; Kang SY; Cho YS; Choi DJ; Kim CH; Kim HS; Oh BH; Choi YH; Kwon IS; Park SC
    Int J Cardiol; 2007 Dec; 123(1):18-22. PubMed ID: 17307262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS.
    Labiós M; Martínez M; Gabriel F; Guiral V; Ruiz-Aja S; Aznar J
    Thromb Res; 2006; 117(4):403-9. PubMed ID: 16461073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
    Jaulmes A; Sansilvestri-Morel P; Rolland-Valognes G; Bernhardt F; Gaertner R; Lockhart BP; Cordi A; Wierzbicki M; Rupin A; Verbeuren TJ
    Thromb Res; 2009 Sep; 124(4):439-46. PubMed ID: 19540572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-effect of p22-phox -930A/G polymorphism on end-organ damage in Brazilian hypertensive patients.
    Sales ML; Ferreira MC; Leme CA; Velloso LA; Gallani MC; Colombo RC; Franchini KG; Nadruz W
    J Hum Hypertens; 2007 Jun; 21(6):504-6. PubMed ID: 17314996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension.
    Rodrigo R; Prat H; Passalacqua W; Araya J; Bächler JP
    Clin Sci (Lond); 2008 May; 114(10):625-34. PubMed ID: 17999638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms regulating urogenital expression of nitric oxide synthase in spontaneously hypertensive rats.
    Yono M; Yoshida M; Yamamoto Y; Imanishi A; Fukagawa A; Latifpour J; Eto M
    Life Sci; 2009 Aug; 85(7-8):334-8. PubMed ID: 19576905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.
    Spirou A; Rizos E; Liberopoulos EN; Kolaitis N; Achimastos A; Tselepis AD; Elisaf M
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):256-61. PubMed ID: 17220472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical ease of using doxazosin in BPH patients with and without hypertension.
    Steers WD; Kirby RS
    Prostate Cancer Prostatic Dis; 2005; 8(2):152-7. PubMed ID: 15711605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients.
    Plantinga Y; Ghiadoni L; Magagna A; Giannarelli C; Franzoni F; Taddei S; Salvetti A
    Am J Hypertens; 2007 Apr; 20(4):392-7. PubMed ID: 17386345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in hypertension: association with antihypertensive treatment.
    Khanna HD; Sinha MK; Khanna S; Tandon R
    Indian J Physiol Pharmacol; 2008; 52(3):283-7. PubMed ID: 19552060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension.
    Derosa G; Cicero AF; D'Angelo A; Tinelli C; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Fogari R
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):508-12. PubMed ID: 16680063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxazosin in the current treatment of hypertension.
    Wykretowicz A; Guzik P; Wysocki H
    Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension.
    Nagae A; Fujita M; Kawarazaki H; Matsui H; Ando K; Fujita T
    Circulation; 2009 Feb; 119(7):978-86. PubMed ID: 19204299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.